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1. Introduction 
Vitreoretinal surgery can be associated with transient or sustained elevated intraocular 
pressure (IOP) as a complication. This may occur in the immediate, early and late post 
operative phase. Secondary glaucoma is a complication of both external procedures (such as 
scleral buckling) and internal procedures (pars plana vitrectomy) including intravitreal 
steroids. Several internal tamponade agents are used in vitreoretinal surgery, such as 
expanding gases and silicone oils which can compromise the aqueous outflow in several 
ways, resulting in secondary glaucoma.  
This chapter will look at the causes of secondary glaucoma complicating vitreoretinal 
procedures. Anderson et al, 2006, looked at 222 patients that underwent vitreoretinal 
procedures and noted that 8.4% had an IOP >30mmHg at 5-12 hours and 14.9% had an 
IOP>30mmHg on the first post operative day, despite all patients receiving topical 
brimonidine tds from 2 hours post operatively. 
2. Intravitreal steroids 
Intravitreal steroids have been used for uveitic and refractory diabetic cystoid macula 
oedema (CMO), CMO secondary to retinal vascular disease, as an adjuvant to laser 
treatment, choroidal neovascular membrane management and in macula hole surgery. The 
use of intravitreal steroids have increased exponentially over the past decade however, in 
the last few years with the advent of the anti VEFG drugs their use is decreasing.  
A well known complication of intra vitreal steroids is secondary glaucoma. Most times it is 
transient; settling with anti glaucoma drugs and discontinuation of steroids. However, a few 
patients can develop intractable glaucoma requiring surgical intervention. The likelihood of 
glaucoma development depends on several factors; pre existing ocular status, family history 
of glaucoma, duration and dosage of steroids. 
Steroid induced glaucoma is usually an open angle glaucoma. It occurs within weeks of 
commencing steroids and usually spontaneously reduces once the steroids are discontinued. 
Some patients are at higher risk of developing glaucoma on steroids, such as those with 
compromised outflow facility, diabetics, myopes and patients with family history of 
glaucoma. Primary open angle glaucoma is seen 4-12 times more commonly in eyes with 
retinal detachment than the normal population (Phelps and Burton, 1977). 
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RISK FACTORS FOR STEROID INDUCED GLAUCOMA 
 Pre existing primary open angle glaucoma (POAG) 
 Diabetes 
 Family history of glaucoma 
 High Myopia 
Table 1. Risk Factors for Steroid Induced glaucoma 
Intravitreal triamcinolone (IVTA) has been noted to cause an increase in intraocular pressure 
which in most cases is transient and responds to anti glaucoma medication. However in a 
small percentage of cases, treatment may require surgical intervention. A significant rise in 
IOP can occur within a week (Singh, 1994). One dose of 4mg intravitreal triamcinolone may 
increase the IOP >10mmHg in 28-30% of patients (Bakri, 2003; Karmar, 2007). In a double 
masked placebo controlled randomized controlled trial, 28% of patients had increased IOP 
requiring treatment (Gilles et al, 2004). 8% of eyes have >40mmHg IOP, with 0.9% requiring 
surgical intervention (Konstantopoulos et al, 2007). Jonas, 2005 had a 40% incidence of elevated 
IOP in patients post IVTA with 1-2% requiring glaucoma surgery. In another study 50% of 
diabetic patients developed elevated IOP within 2 months of IVTA (Yildrim et al, 2008) 
Elevated IOP can occur with a single dose of intravitreal triamcinolone. For continued 
therapeutic level, patients may require repeat intravitreal injections. This increases the risk of 
secondary glaucoma. The fluocinolone acetonide intravitreal device has been designed for 
continuous delivery of low dose steroids (0.3-0.4ug/day) over 30 months and has been used 
effectively in chronic non infectious posterior segment uveitis. However, their clinical trials 
estimate that 77% of patients will require anti glaucoma drugs within 3 years of implantation 
and 37% requiring glaucoma surgical intervention (Retisert Bausch and Lomb, 2009). 
2.1 Pathogenesis 
Steroid induced glaucoma is a type of open angle glaucoma that occurs in patients with 
multiple doses/chronic use of steroids (topical, sub tenons, intra vitreal, nasally or systemic 
route) the exact pathophysiology has yet to be fully elucidated but it is theorized that the 
following may be the cause: 
 
MECHANISM OF SECONDARY GLAUCOMA FOR INTRAVITREAL STEROIDS 
 
 Increased accumulation of glycoaminoglycans 
 Increased production of the Trabecular Meshwork Inducible Glucocorticoid 
Response (TIGR) protein 
 Corticosteroid induced cytoskeletal changes 
 Accumulation of extracellular material in the trabecular network 
 ?High levels of Tissue Inhibitor of Matrix Metalloproteinase  (TIMP) in diabetics 
 
Table 2. Mechanism of Secondary Glaucoma for Intravitreal Steroids 
It is worthwhile to monitor these patients post intravitreal injection particularly patients 
with primary open angle, family history of POAG, pre existing trabecular dysfunction, 
elevated aqueous outflow or ocular hypertension (Jones et al,  2006) . It has the potential to 
www.intechopen.com
 
Secondary Glaucoma After Vitreoretinal Procedures 
 
363 
cause severe visual loss from intractable glaucoma.  Argon laser trabeculoplasty has been 
attempted in 2 patients successfully reducing the IOP (Ricci et al, 2006). SLT has a temporary 
effect on lowering the IOP from steroid induced glaucoma and may need to be repeated in 
4/7 cases (Rubin, 2008).  
In the future gene therapy may have a role in steroid induced glaucoma, due to the 
interference with the glucocorticoid inducible MMP1 (matrix metalloproteinase) (Spriga et 
al, 2010) 
3. Scleral buckling 
Scleral buckling was introduced by Custodis and Schepens in the 1950s for the repair of 
uncomplicated retinal detachments. It involves suturing a silicone band or silicone sponge 
under the recti muscles against the sclera then covering with tenons and conjunctiva. This 
indents the sclera onto the retina,  relieving the traction on the retinal tear, and closing the 
retinal break, thereby allowing the resolution of the subretinal fluid. It may be placed 
radially, segmentally or circumferentially depending on location of the retinal breaks. Very 
posterior or wide band may compress the vortex veins. Scleral buckles are usually 
permanent but may be removed in instances of extrusion or exposure.  
Scleral buckles (especially encircling bands) can change the geometry of an eye (axial length 
and corneal topography) and the ocular rigidity. They cause indentation of the sclera 
decreasing the vitreal volume. Therefore, when the IOP increases, the pressure rise in an eye 
with a scleral buckle is less than a normal eye because the eye becomes less elliptical as the 
scleral sutures are stressed and the indentation reduces (Thompson, 2001). However once 
the eye resumes its more spherical shape the IOP will increase rapidly for increasing 
pressure change. Due to the change in the ocular rigidity, older methods of measuring IOP 
such as the Schiotz tonometer are not as accurate in eyes with scleral buckles. 
3.1 Pathogenesis of secondary glaucoma (scleral buckles) 
Secondary glaucoma occurs after scleral buckling because of angle closure glaucoma. In 1.4 -
4% of cases patients may have angle closure glaucoma (Kreiger et al, 1971 and Perez et al, 
1976). This results in corneal oedema and shallowing of the peripheral angle. It may also be 
due to shallow detachment of the ciliary body, whose anterior displacement may occlude 
the angle, typically occurring 2-7 days post op. Angle narrowing has been detected in 50% of 
cases of non vitrectomized eyes in the first post op week (Hartley & Marsh 1973). However, 
in most cases these resolved spontaneously over several weeks.  
The circumferential encircling band anterior to the equator may compress the vortex veins, 
impairing the venous drainage. This leads to the engorgement of the ciliary body and its 
resulting anterior rotation. This rotation leads to an anterior shift of the lens iris diaphragm 
resulting in secondary angle closure glaucoma.  
Management of the angle closure glaucoma is with anti glaucoma therapy and topical 
corticosteroids. Cycloplegics relax the ciliary muscle and shift the lens-iris diaphragm 
posterior. Miotics are best avoided due their anterior movement of the lens-iris diaphragm 
which can worsen angle narrowing and also inflammation (Gedde, 2002). If it is not relieved 
then reassess the indenting buckle height. Excessive buckle height may be the cause and 
loosening the encircling band may relieve the IOP. 
Glaucoma may also occur with anterior segment ischemia where the posterior ciliary 
arteries are compromised or obstruction of the venous drainage from the ciliary body by the 
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encircling band (Hayreh, 1973). This is usually seen with high buckles or in sickle cell 
patients. They will have corneal oedema, fibrin in the anterior chamber, raised IOP and the 
anterior chamber may be shallow. Mild cases may respond to topical anti glaucoma and 
steroids, however, if severe, releasing the buckle may be necessary. 
 
MECHANISM OF SECONDARY GLAUCOMA FROM SCLERAL BUCKLING 
Angle closure glaucoma 
 Shallow detachment of the ciliary body 
 Very high deep buckle (scleral indentation) 
 Compression of the vortex veins (especially with encircling band) 
 Choroidal congestion 
 Engorgement of the ciliary body (leading to anterior rotation) 
 Anterior shift of the lens iris diaphragm 
Anterior segment ischemia 
Table 3. Mechanism of Secondary Glaucoma from Scleral Buckling 
Anti glaucoma medical therapy is usually successful in controlling IOP. If glaucoma surgery 
is required because of intractable glaucoma, the management can be difficult due to 
conjunctival scarring and recession due to 360 degree or limited periotomies done to place 
the sclera buckle. This may affect the result of trabeculectomy surgery and bleb 
management due to the conjunctival scarring.  
If tube shunts are to be used, the presence of the scleral bands can make surgical 
management challenging in refractory cases. Fran Smith et al, 1998, described 2 techniques 
of using a long Krupin Denver valved implant, where the distal end is placed superior to the 
encircling band but beneath the formed encapsulated fibrous capsule. The proximal end was 
place into the anterior chamber and covered with donor dura or pericardium. The other 
technique involved trimming 200-250mm3 Baerveldt implant wings and placing it under the 
encircling band, before the fibrous sheath forms. The distal lumen was occluded with an 8-0 
supramid stent. Donor dura or pericardium was used to over the anterior episcleral area of 
the tube. 36.4% were complete success (IOP<21mmHg, not on glaucoma meds). The Krupin 
Denver valve was placed in patients 3 months after detachment repair, whereas the 
Baerveldt valve was placed within 3 months, prior to the formation of fibrous capsule 
around the band. However their success rate of IOP< 21mmHg, whether or not on meds 
was 82% and 73% at 1 and 2 years respectively (Fran Smith et al, 1998). 
4. Pneumatic retinopexy 
Intravitreal air was first used by Ohm in 1911 in the management of retinal detachments to 
flatten the retina. Initially air was used to provide internal tamponade for the retinal breaks, 
however, air is non expansible and quickly reabsorbed. Expanding gases are more 
commonly used and these include sulphur hexafluoride (SF6), perfluoroethane (C2F6) and 
perfluoropropane (C3F8) (Table 4). The 2 most commonly used gases are SF6 and C3F8, both 
are colourless, odourless and non toxic gas. SF6 is x5 lighter than air and 100% concentration 
can double in size in 48 hours. It returns to its original size in 96 hours and can last 10-14 
days in the eye (Abrams, 1974). Whereas C3F8 is x6 lighter than air and 100% concentration 
can quadruples in size in 3-4 days and can last 6-8 weeks in the eye. However, they may be 
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used in a mildly expansile format >20% (SF6) and >12% (C3F8) to fill the vitreal cavity after 
pars plana vitrectomy (PPV). 
Pneumatic Retinopexy is a technique in which an expansile gas is injected intravitreally to 
tamponade a retinal tear, to which retinopexy (cryotherapy or laser) has been applied. It  is 
usually performed for simple retinal detachments with single small retinal tears in the 
upper quadrants of the retina. As 100% gas is used the IOP can significantly increase within 
hours (Table 4).  
When intraocular gas is placed in the vitreal cavity, it reduces the ocular rigidity, as it is 
more compressible. (Thompson, 2001). With an intraocular gas filled eye the IOP should be 
measured with applanation tonometry as the change to the ocular rigidity makes the schiotz 
reading inaccurate. 
Properties of Intraocular gases: 
 
EXPANSILE PROPERTIES OF INTRAOCULAR GASES 
Gas Expansibility Of 100% gas Duration in the eye Expanding concentration 
Air Non expansile 5-7 days NA 
SF6 X2 in volume @ 24-48 hours 10-14 days >20% 
C2F8 X3.3 in volume 4-5 weeks >16% 
C3F8 X4 in volume @ 72-96 hours 6-8 weeks >14% 
Table 4. Intraocular gas tamponade agents and their properties 
Central retinal artery occlusion is a very serious complication which may occur in the acute 
case, whilst the gas is expanding. Patients may use topical anti glaucoma drops at the end of 
surgery or be placed on oral diuretics overnight in order to ensure that there is no pressure 
spikes. Patients with pre existing glaucoma or risk factors such as anterior synechiae or 
compromised angles (with reduced outflow) can experience higher IOP spikes. The IOP 
should be measured post operatively and appropriate anti glaucoma treatment instituted if 
required. 
5. Pars Plana Vitrectomy 
Pars plana vitrectomy (PPV) procedure can be done for several reasons including vitreous 
haemorrhage, macular holes, epiretinal membranes, retinal detachment repair and 
proliferative diabetic retinopathy. Adjuvants such as heavy liquid, (perfluorocarbon), 
intraocular gases, silicone oil (1000cs, 5000cs and heavy oil) may be used. Heavy liquid is 
usually removed at the time of the surgery; however other internal tamponade agents may 
be present for weeks to several months depending on the retinal status. Some patients with 
complex retinal detachment may require long term tamponade of the oil, in a few cases, 
because of the high risk of redetachment the VR surgeon may opt not to remove the silicone 
oil. 
Pars plana vitrectomy can induce raised intraocular pressure within 2 hours (Desai, 1997), 
whether on its own or combined with lensectomy, scleral buckling and endolaser due to 
fibrin formation. When pars plana vitrectomy is done, for retinal detachments, intraocular 
gas may be injected to replace the vitreous. Its floatation force and volumetric displacement 
allows the retina to flatten.  
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Intraocular gases may be used in an expansile or non expansile concentration. 
Concentrations >20%, 16% and 14% mixture with of SF6, C2F6 and C3F8  mixture with air are 
expansile respectively (Table 4). Tonometry on gas filled eyes is best done with applanation 
tonometry. Pneumatic tonometry and indentation tonometry underestimated the elevated 
IOP by 25% and 79% respectively (Poliner LS and Schoch LH, 1987) 
5.1 Pathogenesis of Secondary Glaucoma (Intraocular Gases) 
~35% of patients post pars plana vitrectomy develop IOPs>30mmHg within 48 hours (Han 
DP, 1989). It is postulated that the rise in IOP is mainly due to secondary open angle 
mechanisms (Han DP, 1989).  Angle closure mechanisms causing raised IOP have been seen 
in 20% of patients. This occurs because of ciliary body oedema, iridocorneal apposition or 
pupillary block. However 26% of patients may develop late IOP rise which can be secondary 
to neovascular mechanism as seen in diabetics (Aaberg and Van Horn 1978) 
Other mechanisms include pupillary block, mediated by intraocular gas, fibrin or an 
intraocular lens, was the predominant angle-closure mechanism.  
 
MECHANISM OF SECONDARY GLAUCOMA 
FROM VITREORETINAL PROCEDURES WITH INTRAOCULAR GAS 
Secondary Open angle 
Secondary Angle closure  
 due to posterior pressure of the gas  on the iris narrowing the  angle (this is well 
demonstrated in the aphakic patient, who can relieve the pupillary block by 
posturing face down so that the gas bubble moves to the posterior pole and 
aqueous collects in the anterior chamber )  
 ciliary body edema and iridocorneal apposition 
Pupillary block (aphake) 
 Intraocular gas bulging through the pupil. (may be relieved by face down 
posturing) 
Table 5. Mechanism of secondary glaucoma from Intraocular Gas 
Face down post op posturing after macula hole surgery also has 2 roles; in addition to 
tamponading the retina, it keeps the gas bubble away from the lens, and thereby preventing 
a gas induced cataract and pupillary block in an aphakic patient.  
Interestingly acute angle closure glaucoma has been described in the fellow eye during 
prone posturing after a vitreoretinal procedure (Sutter et al, 2003). It was postulated that the 
lens moves anteriorly during prolonged prone posturing. The patients most at risk of angle 
closure include; the Asian, Chinese or Inuit origin, family history, hyperopia, short axial 
length or microphthalmos. Prone position narrow angle test was introduced in 1968. Lying 
prone in a dark room,  causes angle closure  secondary to pupillary block as the lens moves 
anteriorly in an extended prone position provocation test. However, this posture actually 
prevents pupillary block in the eye that has intraocular gas or oil as this floats to tamponade 
the posterior pole (away from the pupil) in prone posturing. 
Supine posturing must be avoided in patients with internal tamponade (gas or oil) as they 
float in the vitreal cavity and cause anterior displacement of the lens resulting in pupillary 
block. Even in the aphakic patient a bubble of gas occluding the pupillary area can produce 
pupillary block glaucoma and this may be relieved with face down posturing which moves 
the internal tamponade agent posterior, away from the pupil, hence aqueous humour can 
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flow in to the anterior chamber. Supine posturing can also cause intraocular gas/oil to affect 
the lens metabolism causing a gas cataract or increasing nuclear sclerosis/posterior capsular 
cataract with gas and oil respectively. 
Air travel is contraindicated in the presence of intraocular gas (Table 6). Acute IOP rise can 
occur if air travel is undertaken or a mountainous climb with intraocular gas as the changes 
in the atmospheric pressure will result in a relatively rapid enlargement of the gas bubble 
which leads to a very high risk to closure of the Central Retinal Artery (CRA). Jackman et al, 
1995 noted that eyes with intraocular gas that underwent hyperbaric oxygen therapy or 
scuba diving had elevated IOPs on return to normal atmospheric pressure. 
 
SITUATIONS TO AVOID IN PATIENTS WITH INTRAOCULAR GAS 
SITUATION MECHANISM of INCREASE IN IOP 
 Air travel 
 Mountainous climb 
 General Anaesthesia with Nitrous 
oxide 
 Supine posturing 
 Scuba diving 
 
 Hyperbaric oxygen therapy 
 Gas expansion (on ascent) 
 Gas expansion (on ascent) 
 Gas expansion (as Nitrous oxide 
diffuses into the intraocular gas) 
 Pupillary block and ‘gas cataract’ 
 Gas expansion on return to normal 
atmospheric pressure 
 Gas expansion on return to normal 
atmospheric pressure 
Table 6. Conditions to avoid in the presence of intraocular gas 
Patients with intraocular gas should not undergo general anaesthesia with nitrous oxide as 
intraoperatively, this gas diffuses rapidly into the intraocular gas bubble and causes rapid 
expansion of the gas bubble, increasing the intraocular pressure. Central retinal artery 
occlusion has been reported in patients who have had general anaesthesia whilst having an 
intraocular gas bubble. There have been several reported cases of irreversible loss of vision 
from use of nitrous oxide during general anaesthesia (Hart, 2002, Kodjikian, 2003 and 
Silvanus et al, 2008) 
In the acute case of elevated IOP, on the first post operative day, topical anti glaucoma 
medications (beta blockers, prostaglandin analogues, carbonic anhydrase inhibitors, alpha 2 
agonists) and oral carbonic anhydrase inhibitors may be used. If the IOPs continue to 
increase, an anterior chamber paracentesis may be done or a small volume of gas may be  
aspirated from the vitreal cavity with a 27G needle and a 1ml syringe. Prophylactic 
treatment with intraoperative  carbonic anhydrase may decrease the pressure in the post 
operative phase (Ruby et al, 1999) and may be routinely used by some VR surgeons. 
6. Silicone oil    
Since the 1960s, silicone oil has being used as a vitreous substitute for long term intraocular 
tamponade in retinal surgery, usually for a period of 2-6 months depending on the type of 
silicone oil, retinal detachment and surgeon’s choice. In some cases of complex retinal 
detachments that oil may be left in long term.  
Silicone Oil is a viscous fluid with the cohesive forces due to the molecular structure and 
hence its resistance to flow. There are 2 main types of silicone oil; that ‘lighter than water’ 
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and the other ‘heavier than water’ oil (Heavy oil). ‘Lighter than water’ oil, floats in the eye  
‘Heavier than water’ oil e.g. Densiron® 68  and Oxane HD, provides long term tamponade 
for inferior retinal problems as this oil sinks in the vitreal cavity. 
Glaucoma complicating vitreoretinal surgical procedures with silicone oil varies from 3-40% 
(Romano et al, 2010). The incidence of Silicone oil induced glaucoma from the silicone oil 
Study report was 8% (Henderer, 1999). The incidence of secondary glaucoma with 
intraocular silicone oil use ranges from 2.2% in 6 months to 56% in 8 months, so  therefore, 
the longer that the oil is present in the eye, the more likely it is to cause secondary glaucoma. 
6.1 Pathogenesis of secondary glaucoma (silicone oil) 
The mechanism for secondary glaucoma includes pupillary block glaucoma, closure of 
peripheral iridectomy, trabecular block with emulsified oil or non emulsified oil, 
inflammation and peripheral synechial angle closure (Table 7). 
Silicone oil can cause pupil block glaucoma in the aphakic patient. Migration of the silicone 
oil into the anterior chamber is a cause of secondary glaucoma (Figure 1). Infiltration into 
the trabecular meshwork of emulsified or non emulsified silicone oil or macrophage oil 
induced endocytosis can result in open angle glaucoma. In addition to a glaucomatous 
pressure dependent optic neuropathy silicone oil may also infiltrate the optic nerve, 
resulting in a granulomatous retrolaminar silicone oil reaction. 
Honavar et al, 1997 studied the effect of silicone oil on 150 eyes with complicated retinal 
detachments. He found that glaucoma antedated the retinal surgery in 13.3% of eyes. 
Silicone oil was the etiologic factor in 70% with neovascular glaucoma being the causative 
factor in 11.7% of cases. Significant positive risk factors for developing glaucoma were; pre 
existing glaucoma, diabetes, trauma, aphakia, silicone oil in the anterior chamber, 
emulsified silicone oil and rubeosis. Myopia and anatomical failure were negative risk 
factors. 
 
 
 
Fig. 1. A bubble of Silicone oil in the Anterior chamber 
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MECHANISMS OF SECONDARY GLAUCOMA FROM 
PROCEDURES WITH SILICONE OIL
 Closure of  Peripheral Iridotomy (by fibrin, blood or residual capsule) 
 Pupillary block (aphake,pseudophake, phakic (with subluxated lens)) 
 Migration of emulsified and non emulsified oil into angle 
 Infiltration of trabecular meshwork (by oil droplets) 
 Inflammation, Trabeculitis (macrophage oil induced endocytosis) 
 Synechial angle closure 
 Overfill of vitreal cavity with silicone oil 
 Pre existing glaucoma/angle pathology 
 Rubeosis iridis 
Table 7. Mechanism of Secondary Glaucoma from Silicone Oil 
6.1.1 Pupillary block glaucoma 
Pupillary block glaucoma occurs in 0.9% of all silicone oil filled eyes (Han DP et al, 1989). This 
condition is more likely to occur in aphakes, where the oil bubble may occlude the pupil, 
obstructing the flow of aqueous humour from the posterior chamber to the anterior chamber. 
Hence for aphakes, a peripheral iridectomy may be done using the vitrector. When ‘lighter 
than water’ oil is used the periphery iridotomy (PI) is done inferiorly (Ando’s peripheral 
iridectomy). ‘Lighter than water’ oil will float, so if it came into the anterior chamber 
obstructing the pupil, an inferior PI would be unobstructed and therefore, maintain the 
equalization of pressure between the anterior and posterior chamber. If ‘heavy oil’ is used the 
PI should be done superiorly as heavy oil remains inferiorly and can block an inferior PI.  
Pupillary block glaucoma may also occur in 6% of pseudophakic and phakic eyes where the 
anterior hyaloid face and zonules are disrupted (Riedel et al, 1990, Jackson T et al, 2001). The 
PI done at the time of the retinal surgery allows the aqueous humour to flow freely from the 
posterior to the anterior chamber thereby eliminating the raised IOP from pupillary block.  
Closure of the PI may occur within the short term because of blood or fibrin or long term 
contracture of the PI, resulting in pupillary block glaucoma if the silicone oil is adjacent to 
the pupil in the aphakic patient. Short term iridotomy failure occurred within 2 days in 31% 
and 85% within a month (Zalta et al, 2007). If the PI closes it may be reopened with the Nd 
YAG. However, Nd YAG laser PI can have a high rate of failure of 78% in reopening inferior 
PIs (Reddy, 1995). An iridotomy effectively reduced the mean IOP by 66% and peripheral 
anterior synechiae by 46% (Zalta et al, 2007).   
The YAG laser may be used where fibrin has occluded the PI. However, t-PA has been used 
successfully to reabsorb the fibrin occluding peripheral iridotomies (Jaffe, 1989). The use of 
intracameral tPA can improve long term patency of the PIs in 40% of cases post laser (Zalta 
et al, 2007). However, 11-33% of peripheral iridotomies will close in the post operative phase 
(Zalta et al, 2007) and this is moreso seen in diabetics or patients with PVR (Madreperla et 
al, 1995). If the patient is phakic the lens usually prevents pupillary block glaucoma and no 
PI is required.  
6.1.2 Silicone oil and the anterior chamber    
If the silicone oil enters the anterior chamber it will float on top of the aqueous humour and 
result in a hyperleon (‘inverted’  or ‘inverse’ hypopyon, if emulsified oil bubbles occur). This 
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can block the outflow from the angles in that area and the emulsified oil may block the 
trabecular meshwork causing an open angle glaucoma (Figure 2). 
Oxane HD and Densiron “heavier than water” oil has a specific gravity of 1.02 g/cm3. When 
dispersed into droplets, one expects them to sink. There has been one reported case of  
emulsification of Oxane HD in an eye that unexpectedly manifested as an "inverted 
hypopyon. 
Oil in the anterior chamber should be removed early to prevent problems with glaucoma. If 
oil is present in the vitreal cavity, care must be taken to ensure that it doesn’t come forward 
during the removal of the oil in the anterior chamber. This can be done with the use of 2 
anterior chamber paracentesis. In one opening viscoelastic is injected into the AC pushing 
the oil towards the other paracentesis site where it is removed. The patient would be placed 
on anti glaucoma drugs until the viscoelastic reabsorbed, which can sometimes be delayed 
in eyes with reduced aqueous outflow. If only one paracentesis is used to aspirate the oil 
from the AC, the oil in the vitreal cavity will come forward to replace it, resulting in more oil 
in the AC. 
 
 
Fig. 2. ‘inverted hypopyon’ , emulsified oil in the Anterior chamber  
6.1.3 Silicone Oil and the lens   
Lensectomy may be done at the time of silicone oil surgery if the patient has a cataract 
which partially occludes the fundal view. If the patient is left pseudophakic, there will be a 
limited barrier to allow oil to float into the anterior chamber. However, in the event that the 
patient is left aphakic (whether or not a capsule is present), a peripheral iridotomy should 
be done. This prevents pupillary block glaucoma by oil. If the regular silicone oil is used an 
inferior peripheral iridotomy is done. If heavy oil is used then a superior peripheral 
iridotomy should be done, as the heavy oil remains in the inferior aspect of the anterior 
chamber and would block an inferior PI. The superior PI in this case allows aqueous 
humour to flow from the posterior chamber to the anterior chamber. This alleviates the 
secondary glaucoma from pupillary block.  
6.1.4 Emulsification: Occlusion of the trabecular meshwork: Open angle glaucoma  
Oil emulsification occurs at interfaces between the oil bubble and ocular tissues or aqueous 
forming small droplets (emulsified oil). These small droplets can pass through the zonules 
via the pupil into the anterior chamber. They may then block the trabecular meshwork, 
either physically or once ingested by macrophages. Silicone oil emulsification occurs in 0.7-
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56% of cases (Valone J and Mc Carthy M, 1994) ). It is a poor prognostic factor for control of 
IOP, odds ratio 15.3 (Honavar, 2001). The longer duration that silicone oil is in the eye, the 
more the likelihood of emulsification. Fibrinogen or fibrin can accelerate the emulsification 
process. Emulsified oil bubbles can be seen on the surface of the iris. If an ‘inverted 
hypopyon’ is not present, gonioscopy may reveal emulsified oil bubbles in the angle. 
Emulsified silicone oil in the anterior chamber must be removed at the time of removal of 
silicone oil (ROSO). If the patient has undergone ROSO already and there is residual 
emulsified oil in the anterior chamber, a single paracentesis site can be made and the 
emulsified oil bubbles removed with active aspiration with a simcoe.  
6.1.5 Heavy oil  
Heavy oil has a higher specific gravity and therefore, tamponade the inferior retinal better 
than conventional oil.  
However shallow anterior chambers (AC) may occur in 1.9% of patients with silicone oil 
filled eyes compared with 5.3% with heavy oil filled eyes at day 1 post op (Romano et al, 
2010). Romano et al, 2010, noted that elevated IOP occurred in 14% and 11.4% of eyes 
normal silicone oil at day 1 and 1 month respectively, compared to 20% and 16% for the 
same period in heavy oil filled eyes. However at 1 year the mean IOP was 16.7mmHg and 
19.7mmHg in the silicone oil and heavy oil groups respectively. This difference was not 
statistically significant (p=0.21, chi-square test).  
However, Wong et al, 2009, showed that Densiron (heavy oil) had a statistically significant 
higher IOP  on the first day and 2 weeks post operatively than silicone oil (P=0.05 and 0.01 
respectively). However, at 4 weeks post operatively there was no statistical difference in the 
IOP between the 2 groups. Heavy oil is removed earlier as it has a higher risk of 
inflammation. Small amounts of emulsification of Densiron induce macrophage activity 
(Hiscott et al, 2001) and increase the level of inflammation in the eye, inducing open angle 
glaucoma. 
Zheng et al, 2010 found an 18.5% incidence of elevated IOP and emulsification each with 
Densiron. However after 3 months post oil removal the IOP returned to <20mmHg. In that 
study 11.1% of eyes became hypotonous after removal of the silicone oil. This can occur 
because of redetachment, proliferation of PVR or because of extensive retinectomies done at 
the time of retinal detachment repair. 
In the silicone oil study 18% of silicone oil eyes and 31% of C3F8 filled eyes had hypotony at 
3 years (Barr CC Lai MY Jean JS, et al 1993). This may be due to extensive  retinectomies (in 
order to repair complex detachment) and not the effect of the oil. Leaving the silicone oil in 
situ in these situations prevents phthisis bulb as it acts a barrier to the reabsorption of 
aqueous via the choroid. 
6.1.6 Management options    
Topical and systemic anti glaucoma medications controlled IOP in 30% of eyes (mean 
number of medications 1.5), with oral acetazolamide required in 7/18 cases. 50% of the eyes 
required chronic glaucoma treatment. Removal of silicone oil (ROSO) alone did not allow 
any of the eyes to achieve normal intraocular pressure. However with ROSO and medical 
therapy 25% achieved normal IOPs. Control of IOPs were achieved in 10/14 eyes that 
underwent surgical intervention. 5/14 that underwent Trabeculectomy + Mitomycin C had 
achieved normal IOP (2 cases with additional medical therapy and one with surgery alone, 
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post ROSO). One patient underwent an anterior chamber tube shunt to the encircling band 
(ACTSEB) and achieved normal IOPs with additional medical therapy. 3 patients underwent 
cyclocryotherapy, with 33% achieving normal IOP without and 33.3% with medical therapy. 
4 patients underwent transcleral cyclophotocoagulation with a 75% success rate of 
controlling the IOP. 
This contrast with Budenz 2001, who looked at the effect of 3 surgical procedures; ROSO 
alone, glaucoma surgery alone and combination of ROSO and Glaucoma surgery for the 
management of persistent raised IOPs. The mean IOP before surgical intervention was 41.4 
+/- 15.1mmHg. 62% of patients that underwent silicone oil removal had their IOPs 
controlled. Of the 38% that failed (of the ROSO alone group), 92% had elevated IOP and 8% 
hypotony. Patients who underwent glaucoma surgery alone had a 50% failure (75% of those 
due to hypotony). However, patients that underwent ROSO and glaucoma surgery had a 
33% failure rate with only 1/3 being from hypotony. 
In patients with Silicone oil induced glaucoma, removal of the oil may reduce the 
intraocular pressure. If the oil is not removed before tube glaucoma surgery, migration of oil 
into tube can occur, even if it is placed inferiorly, with the hope that the oil will float and not 
occlude the tube (Kim and Baumal 2004) 
Nguyen et al reported on intraocular pressure control in 50 eyes with PPV and silicone oil. 
Successful IOP control in 8 of 14 eyes that had ROSO alone and 3 of 5 that had Molteno 
valve implant alone. Only one case had Nd YAG transscleral cyclophotocoagulation which 
was successful. However one case underwent a modified Schocket procedure but didn’t 
achieve normal IOPs. 
Transscleral cyclophotocoagulation has shown successful IOP control in 74-82% of patients 
after 1 year although the visual function was poor in these patients (Bloom et al 1997 and 
Han et al, 1999). Early removal of silicone oil (6/12) has been noted to have reduced risk of 
secondary glaucoma and similar redetachment rates (Han et al 1998). 
7. Conclusion 
The underlying cause of secondary glaucoma after vitreoretinal surgery is often 
multifactorial in nature and may benefit from an exact analysis for an adequate and 
successful treatment regimen. Scleral buckling causes glaucoma that is transitory and settles 
well with topical anti glaucoma medication. Silicone oil related glaucoma can cause a  
refractory glaucoma. 
Patients that underwent pars plana vitrectomy with silicone oil are the most refractory ones 
to treatment and present a surgical challenge. Intraocular pressure elevation is a common 
occurrence after intravitreal silicone oil injection. The underlying mechanism may often be 
multifactorial in nature. Patients in whom uncontrolled IOP develops may benefit from 
aggressive medical and/or surgical treatment with silicone oil removal, glaucoma implants, 
or cyclodestructive procedures. 
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